...
首页> 外文期刊>International Journal of Nephrology and Renovascular Disease >Renal sympathetic denervation increases renal blood volume per cardiac cycle: a serial magnetic resonance imaging study in resistant hypertension
【24h】

Renal sympathetic denervation increases renal blood volume per cardiac cycle: a serial magnetic resonance imaging study in resistant hypertension

机译:肾交感神经去神经增加每个心动周期的肾脏血容量:抵抗性高血压的系列磁共振成像研究

获取原文
           

摘要

Aim: Preclinical studies have demonstrated improvements in renal blood flow after renal sympathetic denervation (RSDN); however, such effects are yet to be confirmed in patients with resistant hypertension. Herein, we assessed the effects of RSDN on renal artery blood flow and diameter at multiple time points post-RSDN. Methods and results: Patients (n=11) with systolic blood pressures ≥160 mmHg despite taking three or more antihypertensive medications at maximum tolerated dose were recruited into this single-center, prospective, non-blinded study. Magnetic resonance imaging indices included renal blood flow and renal artery diameters at baseline, 1 month and 6 months. In addition to significant decreases in blood pressures ( p <0.0001), total volume of blood flow per cardiac cycle increased by 20% from 6.9±2 mL at baseline to 8.4±2 mL ( p =0.003) at 1 month and to 8.0±2?mL ( p =0.04) 6 months post-procedure, with no changes in the renal blood flow. There was a significant decrease in renal artery diameters from 7±2 mm at baseline to 6±1 mm ( p =0.03) at 1 month post-procedure. This decrease was associated with increases in maximum velocity of blood flow from 73±20 cm/s at baseline to 78±19 cm/s at 1 month post-procedure. Notably, both parameters reverted to 7±2 mm and 72±18 cm/s, respectively, 6 months after procedure. Conclusion: RSDN improves renal physiology as evidenced by significant improvements in total volume of blood flow per cardiac cycle. Additionally, for the first time, we identified a transient decrease in renal artery diameters immediately after procedure potentially caused by edema and inflammation that reverted to baseline values 6 months post-procedure.
机译:目的:临床前研究表明,肾交感神经去神经(RSDN)后肾血流量有所改善。然而,这种作用在顽固性高血压患者中尚待证实。本文中,我们评估了RSDN在RSDN后多个时间点对肾动脉血流量和直径的影响。方法和结果:收缩压≥160mmHg的患者(n = 11)尽管以最大耐受剂量服用了三种或更多种降压药,但仍被纳入该单中心,前瞻性,非盲研究。磁共振成像指标包括基线,1个月和6个月时的肾血流量和肾动脉直径。除了血压显着降低(p <0.0001)外,每个心动周期的总血流量从基线时的6.9±2 mL增加20%,在1个月时增加至8.4±2 mL(p = 0.003),并增加至8.0±手术后6个月为2?mL(p = 0.04),肾脏血流没有变化。术后1个月,肾动脉直径从基线的7±2 mm显着减少到6±1 mm(p = 0.03)。这种降低与最大血流速度从基线时的73±20 cm / s增加到术后1个月时的78±19 cm / s有关。值得注意的是,术后六个月,两个参数分别恢复为7±2 mm和72±18 cm / s。结论:RSDN改善了肾脏生理,如每个心动周期总血流量的显着改善所证明。此外,我们首次在手术后6个月立即发现了可能由浮肿和炎症引起的肾动脉直径的短暂减小,该减小可能是由浮肿和炎症引起的。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号